Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients

Journal of Vascular Surgery

Volumn 53, Issue 3, 2011, Pages 668-675

  Saunders, Justin ^a,e   Nambi, Vijay ^a,b   Kimball, Kay T ^c   Virani, Salim S ^a,d   Morrisett, Joel D ^a   Lumsden, Alan B ^b   Ballantyne, Christie M ^a,b   Dong, Jing Fei ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c Statistical Design and Analysis   (United States)

^d MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; ARACHIDONIC ACID; CLOPIDOGREL; COLLAGEN; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; TREATMENT DURATION;

ADENOSINE DIPHOSPHATE; ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; ARACHIDONIC ACID; ASPIRIN; AZETIDINES; DOUBLE-BLIND METHOD; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPOLIPIDEMIC AGENTS; LOWER EXTREMITY; MALE; MIDDLE AGED; NIACIN; PERIPHERAL ARTERIAL DISEASE; PLACEBO EFFECT; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PREDICTIVE VALUE OF TESTS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79951850688     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.08.029     Document Type: Article

References (38)

1. Smith SJ, Allen J, Blair S, Bonow R, Brass L, Fonarow G, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006; 113:2363-72.
2. Vejar M, Fragasso G, Hackett D, Lipkin D, Maseri A, Born G, et al. Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina. Thromb Haemost 1990;63:163-8.
3. Helgason C, Bolin K, Hoff J, Winkler S, Mangat A, Tortorice K, et al. Development of aspirin resistance in persons with previous ischemic stroke. Stroke 1994;25:2331-6. (Pubitemid 24359298)
4. Eikelboom JW, Hirsh J, Weitz JI, Johnston M, Yi Q, Yusuf S. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 2002;105:1650-5. (Pubitemid 34298607)
5. Gum P, Kottke-Marchant K, Welsh P, White J, Topol E. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 2003;41: 961-5. (Pubitemid 36315537)
6. Mueller MR, Salat A, Stangl P, Murabito M, Pulaki S, Boehm D, et al. Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thromb Haemost 1997;78:1003-7. (Pubitemid 27417291)
7. Ziegler S, Maca T, Alt E, Speiser W, Schneider B, Minar E. Monitoring of antiplatelet therapy with the PFA-100 in peripheral angioplasty patients. Platelets 2002;13:493-7. (Pubitemid 35373664)
8. Guthikonda S, Alviar C, Vaduganathan M, Arikan M, Tellez A, DeLao T, et al. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. J Am Coll Cardiol 2008;52:743-9.
9. Nambi V, Kimball K, Bray P, Bergeron A, Johnson S, Morrisett J, et al. Differences in responses of platelets to fluid shear stress in patients with peripheral artery disease (PAD) and coronary artery disease (CAD). Platelets 2009;20:199-205.
10. McGlasson D, Fritsma G. Comparison of four laboratory methods to assess aspirin sensitivity. Blood Coagul Fibrinolysis 2008;19:120-3. (Pubitemid 351252989)
11. Faraday N, Becker D, Yanek L, Herrera-Galeano J, Segal J, Moy T, et al. Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population. Am J Cardiol 2006;98:774-9. (Pubitemid 44301012)
12. Lumsden A, Rice T, Chen C, Zhou W, Lin P, Bray P, et al. Peripheral arterial occlusive disease: magnetic resonance imaging and the role of aggressive medical management. World J Surg 2007;31:695-704. (Pubitemid 46496232)
13. Salzman E. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3′,5′-adenosine monophosphate in human blood platelets. Biochim Biophys Acta 1977;499:48-60. (Pubitemid 8157557)
14. Rao A, Koike K, Willis J, Daniel J, Beckett C, Hassel B, et al. Platelet secretion defect associated with impaired liberation of arachidonic acid and normal myosin light chain phosphorylation. Blood 1984;64: 914-21. (Pubitemid 14003615)
15. Crescente M, Di Castelnuovo A, Iacoviello L, Vermylen J, Cerletti C, de Gaetano G. Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100. A systematic review. Thromb Haemost 2008;99:14-26.
16. Gum P, Kottke-Marchant K, Poggio E, Gurm H, Welsh P, Brooks L, et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 2001;88:230-5. (Pubitemid 32721947)
17. Landis J, Koch G. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74. (Pubitemid 8054849)
18. Linnemann B, Prochnow S, Mani H, Schwonberg J, Lindhoff-Last E. Variability of non-response to aspirin in patients with peripheral arterial occlusive disease during long-term follow-up. Ann Hematol 2009;88: 979-88.
19. Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 2003;41:961-5. (Pubitemid 36315537)
20. Andersen K, Hurlen M, Arnesen H, Seljeflot I. Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease. Thromb Res 2002;108:37-42. (Pubitemid 36197660)
21. Harrison P, Segal H, Silver L, Syed A, Cuthbertson F, Rothwell P. Lack of reproducibility of assessment of aspirin responsiveness by optical aggregometry and two platelet function tests. Platelets 2008;19: 119-24. (Pubitemid 351302375)
22. Fontana P, Nolli S, Reber G, de Moerloose P. Biological effects of aspirin and clopidogrel in a randomized cross-over study in 96 healthy volunteers. J Thromb Haemost 2006;4:813-9.
23. Guthikonda S, Mangalpally K, Vaduganathan M, Patel R, Delao T, Bergeron AL, et al. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy. Thromb Haemost 2008;100:83-9. (Pubitemid 351948749)
24. Robless P, Okonko D, Lintott P, Mansfield A, Mikhailidis D, Stansby G. Increased platelet aggregation and activation in peripheral arterial disease. Eur J Vasc Endovasc Surg 2003;25:16-22. (Pubitemid 36527595)
25. Esposito C, Popescu W, Rinder H, Schwartz J, Smith B, Rinder C. Increased leukocyte-platelet adhesion in patients with graft occlusion after peripheral vascular surgery. Thromb Haemost 2003;90:1128-34. (Pubitemid 38004434)
26. Guthikonda S, Lev E, Patel R, DeLao T, Bergeron A, Dong J, et al. Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin. J Thromb Haemost 2007;5:490-6. (Pubitemid 46680680)
27. Lepäntalo A, Mikkelsson J, Reséndiz J, Viiri L, Backman J, Kankuri E, et al. Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients. Thromb Haemost 2006;95:253-9.
28. Jefferson B, Foster J, McCarthy J, Ginsburg G, Parker A, Kottke-Marchant K, et al. Aspirin resistance and a single gene. Am J Cardiol 2005;95:805-8. (Pubitemid 40332670)
29. Fontana P, Dupont A, Gandrille S, Bachelot-Loza C, Reny J, Aiach M, et al. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation 2003;108:989-95.
30. Bhatt D. Aspirin resistance: more than just a laboratory curiosity. J Am Coll Cardiol 2004;43:1127-9. (Pubitemid 38353001)
31. Santos M, Fuset M, Ruano M, Moscardó A, Valles J. Effect of atorvastatin on platelet thromboxane A(2) synthesis in aspirin-treated patients with acute myocardial infarction. Am J Cardiol 2009;104:1618-23.
32. Tirnaksiz E, Pamukcu B, Oflaz H, Nisanci Y. Effect of high dose statin therapy on platelet function; statins reduce aspirin-resistant platelet aggregation in patients with coronary heart disease. J Thromb Thrombolysis 2009;27:24-8.
33. Puccetti L, Pasqui A, Pastorelli M, Bova G, Cercignani M, Palazzuoli A, et al. Time-dependent effect of statins on platelet function in hypercholesterolaemia. Eur J Clin Invest 2002;32:901-8. (Pubitemid 35478062)
34. Hussein O, Minasian L, Itzkovich Y, Shestatski K, Solomon L, Zidan J. Ezetimibe's effect on platelet aggregation and LDL tendency to peroxidation in hypercholesterolaemia as monotherapy or in addition to simvastatin. Br J Clin Pharmacol 2008;65:637-45. (Pubitemid 351535082)
35. Serebruany V, Malinin A, Aradi D, Kuliczkowski W, Norgard N, Boden W. The in vitro effects of niacin on platelet biomarkers in human volunteers. Thromb Haemost 2010;104:311-7.
36. Cox D, Maree A, Dooley M, Conroy R, Byrne M, Fitzgerald D. Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers. Stroke 2006;37:2153-8. (Pubitemid 44309919)
37. Maree A, Curtin R, Dooley M, Conroy R, Crean P, Cox D, et al. Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease. J Am Coll Cardiol 2005;46:1258-63. (Pubitemid 41615546)
38. Würtz M, Grove E, Kristensen S, Hvas A. The antiplatelet effect of aspirin is reduced by proton pump inhibitors in patients with coronary artery disease. Heart 2010;96:368-71.